Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TPO Receptor Agonists”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)UnknownNCT02877212
What this trial is testing

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75
Post-approval studies (Phase 4)Study completedNCT03119974
What this trial is testing

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

Who this might be right for
Persistent or Chronic ITP
Assistance Publique - Hôpitaux de Paris 48
Large-scale testing (Phase 3)Study completedNCT05220878
What this trial is testing

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Post-approval studies (Phase 4)UnknownNCT05861297
What this trial is testing

Immune Thrombocytopenia Management in Adults

Who this might be right for
Immune Thrombocytopenia Purpura
Nahda University 467
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Post-approval studies (Phase 4)UnknownNCT06009965
What this trial is testing

Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

Who this might be right for
Aplastic AnemiaCSADrug Therapy
Peking Union Medical College Hospital 210
Not applicableStudy completedNCT02298075
What this trial is testing

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 148
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Testing effectiveness (Phase 2)Looking for participantsNCT06613880
What this trial is testing

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaTPO Receptor Agonists
Institute of Hematology & Blood Diseases Hospital, China 48
Not applicableLooking for participantsNCT06568913
What this trial is testing

The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids

Who this might be right for
Persistent or Chronic ITP Not Respnding to Steroids
Sohag University 100
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Not applicableLooking for participantsNCT05931718
What this trial is testing

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

Who this might be right for
Autoimmune Hemolytic AnemiaImmune ThrombocytopeniaChronic Idiopathic Neutropenia+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Post-approval studies (Phase 4)UnknownNCT05311930
What this trial is testing

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69